arcadia

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE530.9011.9 (+2.29 %)
PREV CLOSE ( ) 519.00
OPEN PRICE ( ) 522.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 530.90 (278)
VOLUME 271500
TODAY'S LOW / HIGH ( )522.00 533.75
52 WK LOW / HIGH ( )508.1 678
NSE530.6011.45 (+2.21 %)
PREV CLOSE( ) 519.15
OPEN PRICE ( ) 521.70
BID PRICE (QTY) 530.60 (9961)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3483625
TODAY'S LOW / HIGH( ) 521.10 534.00
52 WK LOW / HIGH ( )507.2 678.45
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
16Nov Cipla trades higher on the BSE
Cipla is currently trading at Rs. 530.60, up by 11.60 points or 2.24% fr..
14Nov Cipla informs about disclosure
Cipla has informed about the disclosure under Regulation 29(2) of SEBI (..
13Nov Cipla’s arm inks agreement with Avenue
InvaGen Pharmaceuticals Inc., a subsidiary of the leading global pharmac..
13Nov Cipla informs about press release
Cipla has informed about the Press Release on acquisition of specialty b..
12Nov Cipla gets approval from USFDA for Val
Cipla has received final approval for its Abbreviated New Drug Applicati..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit5684.714685.2
Gross Profit 7234.3 19114
Operating Profit 8721.725304.3
Net Sales 30947.1114448.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Piramal Enterprises (BSE)
 2341.50 (2.26%)
M.Cap ( in Cr)42933.70
Pfizer (BSE)
 2828.80 (1.80%)
M.Cap ( in Cr)12941.12
Merck (BSE)
 3027.35 (1.36%)
M.Cap ( in Cr)5025.21
Ajanta Pharma (BSE)
 1119.65 (3.36%)
M.Cap ( in Cr)9855.50
Divis Lab (BSE)
 1554.45 (1.54%)
M.Cap ( in Cr)41265.76
Shareholding Pattern
PROMOTERS 36.74%
NON-INSTITUTION 23.81%
MUTUAL FUNDS/UTI 10.99%
FI/BANKS/INSURANCE 2.35%
FII 0.48%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM